Interdisciplinary Maternal Perinatal Australasian Collaborative Trials (IMPACT) Network

The Interdisciplinary Maternal Perinatal Australasian Collaborative Trials (IMPACT) Network was formed in 1994 within the then Australian Perinatal Society and in 1997 became a subcommittee of the Perinatal Society of Australia and New Zealand (PSANZ) dedicated to improvement of maternal and perinatal health by promoting well-designed randomised controlled trials (RCTs), and dissemination and application of their results.

This website has been developed for investigators, health care professionals and consumers to learn more about the conduct of clinical trials, the clinical trials in maternal and perinatal health taking place across Australia and New Zealand, and how the IMPACT Network for Improving Mothers and Babies Health can facilitate the design and set-up, execution and timely completion of these trials.

News & Events

  • Latest IMPACT news...

    Congratulations to William Tarnow-Mordi, his team and all members of the IMPACT Network who were involved with the BOOST II Trial.

    They were awarded First Runner Up in the Australian Clinical Trials Alliance (ACTA) Trial of the Year Award 2017. This prestigious award was announced along with the winner at the Clinical Trials National Tribute and Awards Ceremony held in Sydney on Friday 19th May. This is a fantastic achievement for the trial investigators and great news for the IMPACT Network. Following on from the win by the PPROMT trial last year it is absolutely awesome to again see maternal and perinatal health blazing the trail of clinical trials.

    William Tarnow-Mordi receiving the award from Minister Greg Hunt. 

    May 2017 William Tarnow

     

    19th May was a big day for clinical trials research in Australia as Minister Hunt took the opportunity of the awards ceremony to announce the allocation of $33 million from MRFF and other sources to support clinical trial research.

     

     

     

    Most significantly this included $5 million to ACTA over the next four years to ‘support their work in ensuring Australia maintains its world-leading clinical trial standards and continues to support the clinical trials sector’.  This is unlikely to involve any finances reaching clinical trials networks directly but will still provide support for the work we do and is a big signal for future support of clinical trials.

    See link here for 7 News clip about $33 million federal budget funding allocated to medical trials and featuring IMPACT member Dr Adrienne Gordon

    See link here for Sydney Morning Herald article on premature babies benefiting from practice change as a result of evidence from the BOOST II trial